Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 103 days ( -103.83 % )
Last Price $44.15 0 %
High/ Low $44.15 - $44.15 0%
Chg 7 Days N/A $44.15 $44.15
Chg 30 Days N/A $44.15 $44.15
Chg 12 mos 120.20 % $20.05 $44.15
Trend - 3 mos -0.150 % Width: 0.90 %
Trend - 12 mos 129.57 % Width: 84.69 %
Pred. range - 3 mos $44.02 - $44.42 -0.289 % - 0.611 %
Pred. range - 12 mos $73.00 - $134.82 65.35 % - 205.37 %
Short MA avg 3 mos Sell 2023-03-03 - 60 days
Long MA avg 3 mos Sell 2023-04-13 - 32 days
Short/Long MA avg 3 mos Sell 2023-04-13 - 32 days
Short MA avg 12 mos Sell 2023-03-10 - 55 days
Long MA avg 12 mos Buy 2022-12-28 - 104 days
Short/Long MA avg 12 mos Buy 2023-01-04 - 100 days
Pivot Short Sell 2023-03-02 - 61 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Albireo Pharma Inc

Albireo Pharma Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-th... ALBO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT